Wearable Skin Sensors to Assess Nocturnal Scratch Behavior

A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis

NCT03356977 ·Status: COMPLETED ·Phase: PHASE4

Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis

NCT02975206 ·Status: COMPLETED ·Phase: PHASE2

Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic Dermatitis

NCT00379678 ·Status: COMPLETED

Assessing SleeP IN Infants With Atopic Dermatitis by Longitudinal Evaluation

NCT05031754 ·Status: UNKNOWN

Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments

NCT03051347 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis

NCT00130364 ·Status: COMPLETED ·Phase: PHASE4

Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis

NCT00121381 ·Status: COMPLETED ·Phase: PHASE4

Study Of Atopic Dermatitis In Pediatrics

NCT00257569 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic Pruritus

NCT06787586 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Study of Crisaborole Ointment 2% in Mild to Moderate Atopic Dermatitis

NCT04214197 ·Status: UNKNOWN ·Phase: PHASE4

Clinical Relevance of Scratching and Sleep in Atopic Dermatitis

NCT05467046 ·Status: COMPLETED

Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis

NCT04975438 ·Status: COMPLETED ·Phase: PHASE1

Different Application Rates of Crisaborole Ointment 2% in Adults With Mild to Moderate Atopic Dermatitis

NCT03868098 ·Status: COMPLETED ·Phase: PHASE4

Steroid-reducing Effects of Crisaborole

NCT03832010 ·Status: COMPLETED ·Phase: PHASE4

Sleep & Quality of Life Evaluation of Patients With Atopic Dermatitis Based on E-diary on a Smartphone Application and Actigraphy

NCT03090178 ·Status: COMPLETED ·Phase: NA

Treatment of Chronic Itch in Atopic Dermatitis With Topical Naltrexone

NCT04154033 ·Status: WITHDRAWN ·Phase: PHASE2

Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies

NCT02485704 ·Status: COMPLETED ·Phase: PHASE3

A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic Dermatitis

NCT03260595 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis

NCT02118766 ·Status: COMPLETED ·Phase: PHASE3

Verification Study of Ciclosporin for Atopic Dermatitis

NCT00232076 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Atopic Dermatitis by a Full-Body Blue Light Device

NCT03085303 ·Status: COMPLETED ·Phase: NA

Assessment of Suppression of Cutaneous Allergic Responses and Pruritus by Topical Doxycycline

NCT03968562 ·Status: UNKNOWN ·Phase: PHASE2

Clinical vs. Anecdotal Evidence - Pediatric Atopic Dermatitis

NCT03559075 ·Status: COMPLETED

Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies

NCT02485717 ·Status: COMPLETED ·Phase: PHASE3

PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies

NCT05310734 ·Status: RECRUITING ·Phase: PHASE4